Baseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancer
about
Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases.Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.
P2860
Baseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Baseline hemoglobin and liver ...... y metastatic colorectal cancer
@en
Baseline hemoglobin and liver ...... metastatic colorectal cancer.
@nl
type
label
Baseline hemoglobin and liver ...... y metastatic colorectal cancer
@en
Baseline hemoglobin and liver ...... metastatic colorectal cancer.
@nl
prefLabel
Baseline hemoglobin and liver ...... y metastatic colorectal cancer
@en
Baseline hemoglobin and liver ...... metastatic colorectal cancer.
@nl
P2093
P2860
P356
P1476
Baseline hemoglobin and liver ...... y metastatic colorectal cancer
@en
P2093
Alain Drooz
Andrew S Kennedy
Charles W Nutting
David Ball
Douglas M Coldwell
Edward Ehrenwald
Fred M Moeslein
Michael Cohn
Michael Savin
P2860
P356
10.21037/JGO.2017.01.03
P577
2017-02-01T00:00:00Z